EP. 1: Treatment Options in HER2+ Metastatic Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 2: Trastuzumab Emtansine in HER2+ Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 3: Options in Breast Cancer After HER2+ Targeted TherapyByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 4: Trastuzumab Deruxtecan in HER2+ Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 5: Neratinib + Capecitabine in HER2+ Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 6: Understanding HER2CLIMB Clinical TrialByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 7: Toxicity Management When Using HER2CLIMB RegimenByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 8: Next-Generation Sequencing in HER2+ Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
EP. 9: Newly Approved Agents for HER2+ Breast CancerByTargeted OncologyPublished: July 7th 2020 | Updated: April 27th 2021
